137 related articles for article (PubMed ID: 2454908)
1. Self-inactivation of Fe(II)-bleomycin.
Nakamura M; Peisach J
J Antibiot (Tokyo); 1988 May; 41(5):638-47. PubMed ID: 2454908
[TBL] [Abstract][Full Text] [Related]
2. Oxidation-reduction reactions of iron bleomycin in the absence and presence of DNA.
Goldstein S; Czapski G
Free Radic Res Commun; 1987; 2(4-6):259-70. PubMed ID: 2462530
[TBL] [Abstract][Full Text] [Related]
3. Orientation of iron bleomycin and porphyrin complexes on DNA fibers.
Chikira M; Iiyama T; Sakamoto K; Antholine WE; Petering DH
Inorg Chem; 2000 Apr; 39(8):1779-86. PubMed ID: 12526568
[TBL] [Abstract][Full Text] [Related]
4. The role of the gulose-mannose part of bleomycin in activation of iron-molecular oxygen complexes.
Kénani A; Bailly C; Helbecque N; Catteau JP; Houssin R; Bernier JL; Hénichart JP
Biochem J; 1988 Jul; 253(2):497-504. PubMed ID: 2460080
[TBL] [Abstract][Full Text] [Related]
5. Synthetic analogues and biosynthetic intermediates of bleomycin. Metal-binding, dioxygen interaction, and implication for the role of functional groups in bleomycin action mechanism.
Sugiura Y; Suzuki T; Otsuka M; Kobayashi S; Ohno M; Takita T; Umezawa H
J Biol Chem; 1983 Jan; 258(2):1328-36. PubMed ID: 6185478
[TBL] [Abstract][Full Text] [Related]
6. Evidence for high-valent iron-oxo species active in the DNA breaks mediated by iron-bleomycin.
Pratviel G; Bernadou J; Meunier B
Biochem Pharmacol; 1989 Jan; 38(1):133-40. PubMed ID: 2462877
[TBL] [Abstract][Full Text] [Related]
7. Sequence-specific changes in the metal site of ferric bleomycin induced by the binding of DNA.
Sam JW; Takahashi S; Lippai I; Peisach J; Rousseau DL
J Biol Chem; 1998 Jun; 273(26):16090-7. PubMed ID: 9632661
[TBL] [Abstract][Full Text] [Related]
8. Fe- and Co-bleomycins bound to site specific and nonspecific DNA decamers: comparative binding and reactivity of their metal centers.
Fulmer P; Zhao C; Li W; DeRose E; Antholine WE; Petering DH
Biochemistry; 1997 Apr; 36(14):4367-74. PubMed ID: 9100034
[TBL] [Abstract][Full Text] [Related]
9. Spin-trapping studies of the oxidation-reduction reactions of iron bleomycin in the presence of thiols and buffer.
Antholine WE; Kalyanaraman B; Templin JA; Byrnes RW; Petering DH
Free Radic Biol Med; 1991; 10(2):119-23. PubMed ID: 1707847
[TBL] [Abstract][Full Text] [Related]
10. Chemical synthesis of radiolabeled bleomycin A2 and its binding to DNA.
Roy SN; Orr GA; Brewer CF; Horwitz SB
Cancer Res; 1981 Nov; 41(11 Pt 1):4471-7. PubMed ID: 6171340
[TBL] [Abstract][Full Text] [Related]
11. Iron-bleomycin interactions with oxygen and oxygen analogues. Effects on spectra and drug activity.
Burger RM; Peisach J; Blumberg WE; Horwitz SB
J Biol Chem; 1979 Nov; 254(21):10906-12. PubMed ID: 91607
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin may be activated for DNA cleavage by NADPH-cytochrome P-450 reductase.
Kilkuskie RE; Macdonald TL; Hecht SM
Biochemistry; 1984 Dec; 23(25):6165-71. PubMed ID: 6084519
[TBL] [Abstract][Full Text] [Related]
13. Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA.
Burger RM; Peisach J; Horwitz SB
J Biol Chem; 1981 Nov; 256(22):11636-44. PubMed ID: 6170635
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic studies on bleomycin-iron complexes with carbon monoxide, nitric oxide, isocyanide, azide, and cyanide and comparison with iron-porphyrin complexes.
Sugiura Y; Suzuki T; Kawabe H; Tanaka H; Watanabe K
Biochim Biophys Acta; 1982 May; 716(1):38-44. PubMed ID: 6178437
[TBL] [Abstract][Full Text] [Related]
15. Copper(I) . bleomycin. A structurally unique oxidation-reduction active complex.
Oppenheimer NJ; Chang C; Rodriguez LO; Hecht SM
J Biol Chem; 1981 Feb; 256(4):1514-7. PubMed ID: 6161924
[TBL] [Abstract][Full Text] [Related]
16. Reaction of DNA-bound Co(II)bleomycin with dioxygen.
Xu RX; Antholine WE; Petering DH
J Biol Chem; 1992 Jan; 267(2):950-5. PubMed ID: 1370471
[TBL] [Abstract][Full Text] [Related]
17. ESR studies on the active intermediate in the enzymatic reduction of the Fe-bleomycin complex.
Tero-Kubota S; Ikegami Y; Sugioka K; Nakano M
Biochem Int; 1987 May; 14(5):879-87. PubMed ID: 2457373
[TBL] [Abstract][Full Text] [Related]
18. Mössbauer, EPR and NMR studies of the acid-induced reduction and changes in spin state of ferric bleomycin.
Levy A; Manoharan PT; Rifkind JM; Walker JC; Haberle FC; Kumar NG; Glickson JD; Elgavish GA
Biochim Biophys Acta; 1989 Apr; 991(1):97-108. PubMed ID: 2469484
[TBL] [Abstract][Full Text] [Related]
19. Oxygen transfer reactions by synthetic analogues of iron-bleomycin.
Dawson DY; Hudson SE; Mascharak PK
J Inorg Biochem; 1992 Aug; 47(2):109-17. PubMed ID: 1279119
[TBL] [Abstract][Full Text] [Related]
20. Reduction of copper(II)-bleomycin: a model for in vivo drug activity.
Freedman JH; Horwitz SB; Peisach J
Biochemistry; 1982 Apr; 21(9):2203-10. PubMed ID: 6178433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
